Navigation Links
Bart De Strooper receives prestigious $200,000 Alzheimer Prize
Date:2/29/2008

Leuven, Belgium Alzheimers disease is the most prevalent form of dementia in the Western world. Due to its growing significance in a graying society, some people are calling it the disease of the century. Bart De Strooper (VIB, K.U.Leuven) has been playing a prominent role in researching the processes that underlie this degenerative disease. He has received widespread recognition for his work, both nationally and internationally − and today he receives the MetLife Foundations USD 200,000 Alzheimer Prize. This prestigious prize is awarded to emphasize the importance of fundamental research on Alzheimers disease and highlights the significance of De Stroopers research in the quest for a cure.

Alzheimers disease

Some 24 million people worldwide suffer from dementia, and about half of these people have Alzheimers disease. The growing number of older people is raising the incidence of this disease, and thus scientists predict that, by 2050, there will be some 70 million cases of dementia. In part because were living longer, but also because, within the next 25 years, the post-World War II baby boomer generation will become older than 70 or 80 years of age. Therefore, it is vital that we continue the fight against this disease of the century.

For years now, Bart De Strooper has been conducting pioneering research on Alzheimers disease. He has discovered important mechanisms that lead to this disorder and has uncovered the central role that presenilin plays in the onset of the disease. This finding was the impetus for the global search for remedies. Since then, Bart De Strooper and his research team have continued to unravel the disease processes even further in the ongoing quest for new therapies.

The MetLife Foundation Prize

Since 1986, MetLife Foundation has awarded major prizes to scientists who have made significant contributions to a better understanding of Alzheimers disease. This award program is based on
'/>"/>

Contact: Sooike Stoops
info@vib.be
329-244-6611
VIB (the Flanders Institute for Biotechnology)
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
2. DaVita Receives Civil Complaint
3. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
4. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
5. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
6. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
7. UT Southwesterns obesity research receives $22 million NIH Roadmap grant
8. Temple Emergency Medicine receives $1.8M to find best MRSA treatment
9. Prime Therapeutics Receives TIPPS Certification
10. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
11. UCLA receives $22.5 million to explore the fundamental biology of mental disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 22, 2015 Woodloch Pines, an all-inclusive ... selected by TripAdvisor as the number one best large hotel ... in the world for their annual Travelers’ Choice Awards. ... . The website is home to millions of unbiased and ...
(Date:1/22/2015)... January 22, 2015 Padre Murphy's and Owner ... of Pro Player Health Alliance (PPHA). The PPHA's ... in getting everyone, including NFL greats, treated for obstructive sleep ... leading groups supporting the cause in the valley. The most ...
(Date:1/22/2015)... 22, 2015 The Incredible Bulk is a ... to increase lean muscle by up to 30lbs in less ... attention of HealthyandFitZone.com’s Stan Stevenson, prompting an investigative review. , ... a step-by-step, scientific diet formula that allows the body to ...
(Date:1/22/2015)... Minn. (PRWEB) January 22, 2015 Blue Cross ... those Minnesotans who exemplify what it means to “Live Fearless.” ... chance for people to share their stories about how they ... or simply inspired others by living in the moment. By ...
(Date:1/22/2015)... The federal court overseeing thousands of vaginal ... Southern District of West Virginia has upheld a $2 million ... bellwether trial. In an Order dated January 21st, the Court ... that C.R. Bard had not proven a miscarriage of justice. ...
Breaking Medicine News(10 mins):Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 3Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 3Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4
... By Serena Gordon HealthDay Reporter , WEDNESDAY, Aug. ... doubt heard plaintive wails from your child as you traverse ... you may have wondered, what makes even preschoolers yearn so ... meal in the brightly colored box? New research ...
... Hamilton, ON (August 17, 2011) Active children ... effective way of countering dehydration than a sports drink ... That,s particularly important during hot summer weather, says Brian ... Medicine Program at McMaster and principal investigator of the ...
... -- Elderly people with extra body fat may not live ... to a new study that contradicts previous research. In ... for changes in their weight, researchers found a higher body ... shorter life expectancy. "We had a unique opportunity to ...
... $25 billion is spent annually on treating chronic wounds on ... the quality of life of more than six million people ... wounds and skin ulcers are related to venous disease (conditions ... abnormal). Many treatment options are available, but the quality of ...
... , WEDNESDAY, Aug. 17 (HealthDay News) -- ... than one-third of lower leg injuries treated in U.S. ... Alternative approaches to treatment, such as an emergency hotline ... emergency department resources, researchers from Massachusetts General Hospital in ...
... 16, 2011) A co-worker,s rudeness can have a great ... Baylor University study published online in the Journal of ... can be so intense that, at the end of the ... the well-being of the worker,s family and partner, who in ...
Cached Medicine News:Health News:Cartoon Characters Prod Kids to Nag for Unhealthy Foods 2Health News:Cartoon Characters Prod Kids to Nag for Unhealthy Foods 3Health News:Being Overweight May Take Years Off Seniors' Lives 2Health News:Johns Hopkins Evidence-based Practice Center awarded $475,000 project 2Health News:Johns Hopkins Evidence-based Practice Center awarded $475,000 project 3Health News:Sprained Ankles Straining ER Resources, Study Finds 2Health News:Baylor University study finds consequences of co-worker rudeness are far-reaching 2
(Date:1/23/2015)... BETHESDA, Md. , Jan. 23, 2015  Northwest Biotherapeutics, Inc. ... developing DCVax® personalized immune therapies for operable and inoperable solid ... will present at the 7 th Annual Phacilitate Immunotherapy ... NW Bio,s presentation at Phacilitate will take place on January ...
(Date:1/23/2015)...  Pete Rose, baseball,s all-time hits leader, is the new spokesperson ... Ducere Pharma has announced. "Pete,s a Hall of ... him on board with Myoflex," said Ducere Pharma Chief Executive ... who is known across all generations. The passion and intensity ...
(Date:1/23/2015)... Cord Blood America, Inc. ( www.cordblood-america.com ) (OTC Bulletin ... a Preliminary Proxy Statement, Schedule 14A, with the U.S. Securities ... update for shareholders detailing why a "YES" vote to increase ... Shareholders, As we reflect upon the 2014 fiscal ...
Breaking Medicine Technology:NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 2NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 3Pete Rose bets on Myoflex to relieve aches and pains 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 3Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 4
... 8, 2012  Janssen Research & Development, LLC today ... study of ZYTIGA® (abiraterone acetate) plus prednisone for ... with metastatic castration-resistant prostate cancer (CRPC) who have ... is an international, randomized, double-blind, placebo controlled study that ...
... 2012  For many women, the decision to get pregnant can ... to a survey conducted for SpermCheck® Fertility , 42% ... pregnant once they started trying. Yet just 10% say their ... million couples will experience conception issues and about 50% of ...
Cached Medicine Technology:Study Unblinded: ZYTIGA® (abiraterone acetate) Plus Prednisone for Asymptomatic or Mildly Symptomatic Chemotherapy-Naive Patients with Metastatic Castration-Resistant Prostate Cancer 2Study Unblinded: ZYTIGA® (abiraterone acetate) Plus Prednisone for Asymptomatic or Mildly Symptomatic Chemotherapy-Naive Patients with Metastatic Castration-Resistant Prostate Cancer 3Study Unblinded: ZYTIGA® (abiraterone acetate) Plus Prednisone for Asymptomatic or Mildly Symptomatic Chemotherapy-Naive Patients with Metastatic Castration-Resistant Prostate Cancer 4Study Unblinded: ZYTIGA® (abiraterone acetate) Plus Prednisone for Asymptomatic or Mildly Symptomatic Chemotherapy-Naive Patients with Metastatic Castration-Resistant Prostate Cancer 5Study Unblinded: ZYTIGA® (abiraterone acetate) Plus Prednisone for Asymptomatic or Mildly Symptomatic Chemotherapy-Naive Patients with Metastatic Castration-Resistant Prostate Cancer 6Perceptions on Conception 2Perceptions on Conception 3
Anterior Chamber Needle, 30 g. Angled. 5 mm angled tip. Overall length 20 mm. 5/box....
Anterior Chamber Needle, 23 g. Angled. 7 mm angled tip. Overall length 23 mm. 5/box....
Anterior Chamber Needle, 20 g. Angled. 7 mm angled tip. Overall length 23 mm. 5/box....
Hydrodissection / Aspiration Cannula, 25 g. Angled with right hook. 10 mm angled shaft with 2.5 mm right hook tip. Overall length 20 mm. 5/box....
Medicine Products: